Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery

Ultrasound stimulated drug delivery is attractive for controlled dose and localised delivery to reduce excess loss of drug and side effects, which for antibiotics is pertinent to the fight against antimicrobial resistance. Low frequency ultrasound is commonly used in dental clinical practice for bac...

Full description

Saved in:
Bibliographic Details
Main Authors: Grace Ball, Jack Stevenson, Faraz Amini Boroujeni, Ben Jacobson, Sarah A. Kuehne, Margaret Lucas, Anthony Damien Walmsley, Paul Prentice, Zoe Pikramenou
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Ultrasonics Sonochemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1350417725000951
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850186103158472704
author Grace Ball
Jack Stevenson
Faraz Amini Boroujeni
Ben Jacobson
Sarah A. Kuehne
Margaret Lucas
Anthony Damien Walmsley
Paul Prentice
Zoe Pikramenou
author_facet Grace Ball
Jack Stevenson
Faraz Amini Boroujeni
Ben Jacobson
Sarah A. Kuehne
Margaret Lucas
Anthony Damien Walmsley
Paul Prentice
Zoe Pikramenou
author_sort Grace Ball
collection DOAJ
description Ultrasound stimulated drug delivery is attractive for controlled dose and localised delivery to reduce excess loss of drug and side effects, which for antibiotics is pertinent to the fight against antimicrobial resistance. Low frequency ultrasound is commonly used in dental clinical practice for bacterial biofilm removal and is an attractive versatile stimulus for drug release. Here we introduce nonporous (amorphous) silica nanoparticles as a biocompatible, encapsulant for triggered drug release by low frequency ultrasound. A 20 kHz ultrasonic sonotrode is used in to evaluate the release of the antibiotic ciprofloxacin, CPX, from non-porous particles, CPX ⊂ SiO2. Laser doppler vibrometry (LDV) was employed to characterise the ultrasonic vibration displacement of the sonotrode. Drug release from CPX ⊂ SiO2 was monitored for increasing the tip displacement. Clinically relevant quantities of CPX release (5.7 mg/L) occurred at 40 μm tip displacement in our studies. A strong correlation was observed between cavitation features in the acoustic spectra and drug release from CPX ⊂ SiO2. Silica nanoparticles with and without encapsulated CPX, CPX ⊂ SiO2 and SiO2, respectively, were found to promote cavitation at lower amplitudes confirmed by high-speed imaging, in contrast to mesoporous particles with and without adsorbed CPX, CPX@m-SiO2 and m-SiO2. Spectra of the emissions collected via an acoustic cavitation detector supported these results. Our studies demonstrate a novel platform for drug delivery employing low frequency ultrasound for synergistic enhancement of cavitation effects and triggered drug release.
format Article
id doaj-art-4f2585e214b44448b58c7dc02767e7aa
institution OA Journals
issn 1350-4177
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series Ultrasonics Sonochemistry
spelling doaj-art-4f2585e214b44448b58c7dc02767e7aa2025-08-20T02:16:29ZengElsevierUltrasonics Sonochemistry1350-41772025-05-0111610731610.1016/j.ultsonch.2025.107316Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic deliveryGrace Ball0Jack Stevenson1Faraz Amini Boroujeni2Ben Jacobson3Sarah A. Kuehne4Margaret Lucas5Anthony Damien Walmsley6Paul Prentice7Zoe Pikramenou8School of Chemistry, University of Birmingham, Edgbaston B15 2TT, UKCentre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UKCentre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UKCentre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UKSchool of Science & Technology, Nottingham Trent University, Nottingham NG11 8NS, UKCentre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UKSchool of Dentistry, College of Medical and Dental Sciences, University of Birmingham, Birmingham B5 7EG, UKCentre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UKSchool of Chemistry, University of Birmingham, Edgbaston B15 2TT, UK; Corresponding author.Ultrasound stimulated drug delivery is attractive for controlled dose and localised delivery to reduce excess loss of drug and side effects, which for antibiotics is pertinent to the fight against antimicrobial resistance. Low frequency ultrasound is commonly used in dental clinical practice for bacterial biofilm removal and is an attractive versatile stimulus for drug release. Here we introduce nonporous (amorphous) silica nanoparticles as a biocompatible, encapsulant for triggered drug release by low frequency ultrasound. A 20 kHz ultrasonic sonotrode is used in to evaluate the release of the antibiotic ciprofloxacin, CPX, from non-porous particles, CPX ⊂ SiO2. Laser doppler vibrometry (LDV) was employed to characterise the ultrasonic vibration displacement of the sonotrode. Drug release from CPX ⊂ SiO2 was monitored for increasing the tip displacement. Clinically relevant quantities of CPX release (5.7 mg/L) occurred at 40 μm tip displacement in our studies. A strong correlation was observed between cavitation features in the acoustic spectra and drug release from CPX ⊂ SiO2. Silica nanoparticles with and without encapsulated CPX, CPX ⊂ SiO2 and SiO2, respectively, were found to promote cavitation at lower amplitudes confirmed by high-speed imaging, in contrast to mesoporous particles with and without adsorbed CPX, CPX@m-SiO2 and m-SiO2. Spectra of the emissions collected via an acoustic cavitation detector supported these results. Our studies demonstrate a novel platform for drug delivery employing low frequency ultrasound for synergistic enhancement of cavitation effects and triggered drug release.http://www.sciencedirect.com/science/article/pii/S1350417725000951UltrasoundCavitation responsiveSilica nanoparticlesControlled drug release
spellingShingle Grace Ball
Jack Stevenson
Faraz Amini Boroujeni
Ben Jacobson
Sarah A. Kuehne
Margaret Lucas
Anthony Damien Walmsley
Paul Prentice
Zoe Pikramenou
Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
Ultrasonics Sonochemistry
Ultrasound
Cavitation responsive
Silica nanoparticles
Controlled drug release
title Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
title_full Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
title_fullStr Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
title_full_unstemmed Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
title_short Non-porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
title_sort non porous silica nanoparticles as a cavitation sensitive vehicle for antibiotic delivery
topic Ultrasound
Cavitation responsive
Silica nanoparticles
Controlled drug release
url http://www.sciencedirect.com/science/article/pii/S1350417725000951
work_keys_str_mv AT graceball nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT jackstevenson nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT farazaminiboroujeni nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT benjacobson nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT sarahakuehne nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT margaretlucas nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT anthonydamienwalmsley nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT paulprentice nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery
AT zoepikramenou nonporoussilicananoparticlesasacavitationsensitivevehicleforantibioticdelivery